Skip to content
Riskpilot
← Back to search
Sign in
Get full access
JRS Pharma Oy
OY
Active
Y-tunnus 0759910-8
Maitotie 4, 15560
Nastola
Manufacture of other chemical products n.e.c.
· NACE 2059
Est. 1989 · 36 years old
29 employees
Share
Finland
/
Companies
/
Manufacture of other chemical products n.e.c.
/
JRS Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
6M
12M
17M
23M
13M
2020
15M
2021
18M
2022
18M
2023
20M
2024
EBITDA
EUR millions
9M
7M
4M
2M
0M
3M
2020
3M
0%
2021
4M
+33%
2022
7M
+75%
2023
6M
-14%
2024
Income statement
EUR thousands
Item
2020
2021
2022
2023
2024
Revenue
13 233
15 468
17 868
17 846
19 791
Staff expenses
−1 548
−1 637
−1 802
−1 942
−1 991
EBITDA
3 414
2 800
4 386
6 825
5 938
Depreciation & amort.
−67
−60
−79
−385
−1 094
EBIT
3 347
2 739
4 306
6 440
4 844
Net financials
−5
3
−44
−716
−975
Profit before tax
3 342
2 742
3 912
5 171
906
Tax
699
549
782
1 036
183
Net profit
2 643
2 192
3 130
4 136
723
Balance sheet
EUR thousands
Item
2020
2021
2022
2023
2024
Total assets
11 302
13 535
30 405
42 309
48 059
Equity
8 926
11 118
14 527
18 383
19 106
Long-term debt
—
—
10 070
20 000
23 000
Short-term debt
2 377
2 417
5 807
3 022
2 087
Total debt
2 377
2 417
15 877
23 022
25 087
Financial ratios
5-year trend
EBITDA margin
30.0%
This company
15.8%
Market median
+90% vs market
2020
2024
Equity ratio
39.8%
This company
38.2%
Market median
+4% vs market
2020
2024
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
2020
2024
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
2020
2024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
2020
2024
Debt / equity
1.52×
This company
0.62×
Market median
-145% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
More on JRS Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
